Tìm theo
rhGAD65
Các tên gọi khác (1) :
  • Recombinant human GAD65
Vaccine
Thuốc Gốc
Biotech
rhGAD65 (recombinant human glutamic acid decarboxylase) is a vaccine being developed to treat insulin dependent type 1 diabetes.
Dược Lực Học : The immune system of patients treated with rhGAD65 demonstrate an increase in the secretion of several immunomodulatory substances, dominated by regulatory cytokines, including IL5, IL13, IL10, IL17, IFN-a and TNF-a. Additionally, the activity of T-cells in response to GAD65 is increased with rhGAD65 therapy and subjects receiving rhGAD65 show an up regulation of cytokines in response to GAD65.
Chỉ Định : Investigated for use/treatment in diabetes mellitus type 1.
Dữ Kiện Thương Mại
Nhà Sản Xuất
  • Công ty :
    Sản phẩm biệt dược : Diamyd
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB04963
... loading
... loading